Bayesian Capital Management, LP Inovio Pharmaceuticals, Inc. Transaction History

Bayesian Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$6.23 - $10.03 $256,053 - $412,233	-41,100 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$8.81 - $16.96 $218,012 - $419,692	24,746 Added 151.31%	41,100 $381,000
Q4 2020 Feb 12, 2021	SELL	$8.5 - $12.85 $1.32 Million - $1.99 Million	-154,846 Reduced 90.45%	16,354 $145,000
Q3 2020 Nov 12, 2020	BUY	$9.57 - $27.05 $1.64 Million - $4.63 Million	171,200 New	171,200 $1.99 Million
Q2 2020 Aug 14, 2020	SELL	$7.14 - $31.69 $362,704 - $1.61 Million	-50,799 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.98 - $14.09 $151,381 - $715,757	50,799 New	50,799 $378,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $519M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.